This site uses cookies. By continuing to browse the site you are agreeing to our cookie policy.

None
Corporate Information
Login
Register
Professional Investor
  • About Us
    • Our Business
    • Our Culture
    • Management Team
    • Investment Teams
    • Capacity Management
    • Press Releases
  • Our Funds
    • Our Funds
    • Explore Our Funds
    • Latest Fact Sheets
    • Fund Prices
    • Dealing

    Regional

    • Asian Stars
    • China Stars
    • Emerging Market Stars
    • Emerging Market ex-China Stars
    • European ex UK Income
    • Japan Value
    • North American
    • UK Value Opportunities

    SICAV

    • Melchior European Opportunities

    Thematic & Sector

    • Artificial Intelligence
    • Biotechnology
    • Emerging Markets Healthcare
    • Financial Credit
    • Global Insurance
    • Global Technology
    • Healthcare Blue Chip
    • Healthcare Discovery
    • Healthcare Opportunities
    • Smart Energy
    • Smart Mobility

    Alternative

    • Global Absolute Return
    • Global Convertible

    Investment Trusts

    • Polar Capital Global Financials Trust plc
    • Polar Capital Global Healthcare Trust plc
    • Polar Capital Technology Trust plc
  • ESG & Sustainability
    • Responsible Investing
    • Corporate Responsibility
  • Insights
    • Investment Insights
    • Events & Webcasts
  • Literature & Prices
    • Literature Library
    • Fund Prices
    • Latest Fact Sheets
    • Shareholder Notifications
    • Tax & Reporting
  • Contact Us
    • Contact Us
    • Protect Against Fraud
    • Complaints Policy
    • Consumer Duty
    • Web Accessibility
  • Investor Relations
  • Register
  • Terms & Conditions
  • Privacy Notice
  • Cookie Policy
  • Glossary

Investment insights

Investment Insights

  • Events & Webcasts
Go to main site

Related insights

Artificial Intelligence

AI disruption deepens and opportunities broaden

Xuesong Zhao,Nick Dumas-Williams5 Jan 2026
Healthcare

Increasing fundamental clarity offering timely growth alternative

Gareth Powell,James Douglas5 Jan 2026
Emerging Markets

Positive trends should continue for emerging markets

Jorry Nøddekær5 Jan 2026

Most viewed insights

fbc None
Artificial Intelligence

AI disruption deepens and opportunities broaden

Xuesong Zhao, Nick Dumas-Williams
5 Jan 2026
fbc None
Technology

2026: The year AI’s impact becomes impossible to ignore

Nick Evans, Ben Rogoff
5 Jan 2026
fbc None
Global Healthcare

Healthcare utilisation: a structural growth story for long-term investors

Gareth Powell
9 Dec 2025
fbc None
Emerging Markets

Positive trends should continue for emerging markets

Jorry Nøddekær
5 Jan 2026

Related insights

None
Artificial Intelligence

AI disruption deepens and opportunities broaden

Xuesong Zhao, Nick Dumas-Williams
5 Jan 2026
None
Healthcare

Increasing fundamental clarity offering timely growth alternative

Gareth Powell, James Douglas
5 Jan 2026
None
Emerging Markets

Positive trends should continue for emerging markets

Jorry Nøddekær
5 Jan 2026

Most viewed insights

Artificial Intelligence

AI disruption deepens and opportunities broaden

Xuesong Zhao, Nick Dumas-Williams5 Jan 2026
Technology

2026: The year AI’s impact becomes impossible to ignore

Nick Evans, Ben Rogoff5 Jan 2026
Global Healthcare

Healthcare utilisation: a structural growth story for long-term investors

Gareth Powell9 Dec 2025
Emerging Markets

Positive trends should continue for emerging markets

Jorry Nøddekær5 Jan 2026

Latest insights

Artificial Intelligence

AI disruption deepens and opportunities broaden

Xuesong Zhao, Nick Dumas-Williams5 Jan 2026
Healthcare

Increasing fundamental clarity offering timely growth alternative

Gareth Powell, James Douglas5 Jan 2026
Emerging Markets

Positive trends should continue for emerging markets

Jorry Nøddekær5 Jan 2026
Technology

2026: The year AI’s impact becomes impossible to ignore

Nick Evans, Ben Rogoff5 Jan 2026
  • Protect Against Fraud
  • Terms & Conditions
  • Privacy Notice
  • Cookie Policy
  • Complaints Policy
  • Anti-Slavery Statement
  • Glossary
  • Web Accessibility
  • Careers
  • Contact Us

Polar Capital LLP is a limited liability partnership registered in England and Wales with registration number OC314700. It is authorised and regulated by the UK Financial Conduct Authority and is registered as an investment advisor with the US Securities & Exchange Commission. A list of members is open to inspection at the registered office, 16 Palace Street, London SW1E 5JD, United Kingdom.

© 2026 Polar Capital. All Rights Reserved
Site by HSL

Login

Please check your email address and password.
Forgot password?|Register
Back

Please enter the email address you used to register for this site. You will be sent an email to reset your password.


Sorry, we were unable to find a user with that email address.

For assistance please telephone +44 (0) 20 7227 2700 or email investor-relations@polarcapital.co.uk

If we recognised your email, we'll have sent you a link to reset your password.

Done

Terms and Conditions

CancelAccept
  • Our Funds
  • Explore Our Funds
  • Dealing

Regional

  • Asian Stars
  • China Stars
  • Emerging Market Stars
  • Emerging Market ex-China Stars
  • European ex UK Income
  • Japan Value
  • North American
  • UK Value Opportunities

SICAV

  • Melchior European Opportunities

Thematic & Sector

  • Artificial Intelligence
  • Biotechnology
  • Emerging Markets Healthcare
  • Financial Credit
  • Global Insurance
  • Global Technology
  • Healthcare Blue Chip
  • Healthcare Discovery
  • Healthcare Opportunities
  • Smart Energy
  • Smart Mobility

Alternative

  • Global Absolute Return
  • Global Convertible

Investment Trusts

  • Polar Capital Global Financials Trust plc
  • Polar Capital Global Healthcare Trust plc
  • Polar Capital Technology Trust plc